Crossmark

Comparative efficacy of different therapeutic approaches in treatment naïve FLT3-mutated AML eligible for intensive chemotherapy: a Bayesian network meta-analysis of randomized trials

Crossref DOI link: https://doi.org/10.1007/s00277-026-06948-8

Published Online: 2026-04-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bruzzese, Antonella

Lofaro, Danilo

Martino, Enrica Antonia

Mendicino, Francesco

Labanca, Caterina

Caserta, Santino

Lucia, Eugenio

Olivito, Virginia

Amodio, Nicola

Morabito, Fortunato

Vigna, Ernesto

Gentile, Massimo
Funding

Funding for this research was provided by:

Università della Calabria
License Information

Text and Data Mining valid from 2026-04-06

Version of Record valid from 2026-04-06
More Information

Article History

Received: 6 January 2026

Accepted: 11 March 2026

First Online: 6 April 2026

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below